...Good afternoon and welcome to Genmab's 2025 Annual General Meeting. We are pleased to once again see so many of you in person. Welcome as well to those of you joining us via webcast. I'm Deirdre Connelly, Chair of Genmab's Board of Directors. I would like to begin by introducing the other members of our Board: Deputy Chair Pernille Erenbjerg, as well as Anders Gersel Pedersen, Rolf Hoffmann, Elizabeth O'Farrell, and Paolo Paoletti. We also have three newly elected employee Board members. These are Martin Schultz, Michael Kavanagh, and Mijke Zachariasse. I would like to thank our previous employee Board member Takahiro Hamatani for his contributions over the years. Next, I would like to introduce our executive managers. Jan Van de Winkel, Genmab's Chief Executive Officer; and Anthony Pagano, our Chief Financial Officer. In the audience today, we also have Judith Klimovsky, our Chief Development Officer; Brad Bailey, Chief Commercial Officer; Tahi Ahmadi, Chief Medical Officer; Birgitte Stephensen,...